Aavitsland P, Lystad A
Avdeling for Samfunnsmedisin Statens Institutt for Folkehelse, Oslo.
Tidsskr Nor Laegeforen. 1993 Mar 10;113(7):821-4.
We surveyed routine practice among a random sample of 302 Norwegian general practitioners. 49% perform a test of cure in all the patients whom they treat for genital infection caused by Chlamydia trachomatis. 22% of the practitioners test "most" patients, 19% test "some" patients while 10% of the general practitioners test none of the patients after treatment for genital chlamydial infection. Female practitioners perform more tests of cure than male practitioners do. Most tests are performed 1-4 weeks after completion of treatment. Although test of cure has been a controversial topic, we believe it to be a useful measure against the epidemic of genital chlamydial infections. The purposes of the test are to establish whether or not the treatment has been effective and ensure that the patient has not been reinfected by a partner who did not receive treatment. The test of cure must be performed later than two weeks after completion of treatment, in order to avoid false positive tests as a result of residual chlamydial antigen in the genitalia.
我们对302名挪威全科医生的随机样本进行了常规诊疗调查。49%的医生会对所有接受沙眼衣原体引起的生殖器感染治疗的患者进行治愈检测。22%的医生对“大多数”患者进行检测，19%的医生对“一些”患者进行检测，而10%的全科医生在患者接受生殖器衣原体感染治疗后不对任何患者进行检测。女医生进行的治愈检测比男医生多。大多数检测在治疗结束后的1至4周进行。尽管治愈检测一直是一个有争议的话题，但我们认为它是对抗生殖器衣原体感染流行的一项有用措施。该检测的目的是确定治疗是否有效，并确保患者没有被未接受治疗的性伴侣再次感染。治愈检测必须在治疗结束两周后进行，以避免因生殖器中残留衣原体抗原导致假阳性检测。
